Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cashflow Statement

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr₹569 Cr
Adjustment ₹134 Cr₹102 Cr₹124 Cr₹62 Cr₹54 Cr
Changes In working Capital ₹-309 Cr₹63 Cr₹-231 Cr₹-213 Cr₹-98 Cr
Cash Flow after changes in Working Capital ₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr₹525 Cr
Cash Flow from Operating Activities ₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr₹417 Cr
Cash Flow from Investing Activities ₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr₹-167 Cr
Cash Flow from Financing Activities ₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr
Net Cash Inflow / Outflow ₹-68 Cr₹9.00 Cr₹76 Cr₹9.80 Cr₹-0.50 Cr
Opening Cash & Cash Equivalents ₹132 Cr₹111 Cr₹26 Cr₹20 Cr₹28 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹6.50 Cr₹12 Cr₹9.30 Cr₹-3.80 Cr₹-8.00 Cr
Closing Cash & Cash Equivalent ₹70 Cr₹132 Cr₹111 Cr₹26 Cr₹20 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,240.5 Cr -5.8% 3.6% -13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,126.0 Cr 1.4% 4.1% 18.7% Stock Analytics
DIVIS LABORATORIES ₹161,568.0 Cr -2.1% 4.2% 59.1% Stock Analytics
CIPLA ₹125,156.0 Cr -0.1% 5% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,176.0 Cr -0.3% 3% 23.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,716.1 Cr -1.5% 1.7% -5.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.8%

3.6%

-13.6%

SENSEX

0.2%

2.9%

8.7%


You may also like the below Video Courses